0001770141-24-000052.txt : 20240412 0001770141-24-000052.hdr.sgml : 20240412 20240412160318 ACCESSION NUMBER: 0001770141-24-000052 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20240411 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240412 DATE AS OF CHANGE: 20240412 FILER: COMPANY DATA: COMPANY CONFORMED NAME: UpHealth, Inc. CENTRAL INDEX KEY: 0001770141 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HEALTH SERVICES [8000] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 833838045 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38924 FILM NUMBER: 24841401 BUSINESS ADDRESS: STREET 1: 14000 S. MILITARY TRAIL STREET 2: SUITE 203 CITY: DELRAY BEACH STATE: FL ZIP: 33484 BUSINESS PHONE: 888.424.3646 MAIL ADDRESS: STREET 1: 14000 S. MILITARY TRAIL STREET 2: SUITE 203 CITY: DELRAY BEACH STATE: FL ZIP: 33484 FORMER COMPANY: FORMER CONFORMED NAME: GigCapital2, Inc. DATE OF NAME CHANGE: 20190308 8-K 1 uph-20240411.htm 8-K uph-20240411
0001770141false00017701412024-04-112024-04-11

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

April 11, 2024
Date of Report (date of earliest event reported)

UpHealth, Inc.
(Exact name of registrant as specified in its charter)
Delaware
(State or other jurisdiction
 of incorporation or organization)
001-38924
(Commission
 File Number)
83-3838045
(I.R.S. Employer
 Identification Number)
14000 S. Military Trail, Suite 203
Delray Beach, FL 33484
(Address of principal executive offices, including zip code)
(888) 424-3646
(Registrant's telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e 4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading
 Symbols
Name of each exchange
on which registered
Common Stock, par value $0.0001 per share
UPH(1)
New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company  
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  





___________________________________________________
(1)On December 11, 2023, UpHealth, Inc. (the “Company”) received written notice from the staff of NYSE Regulation that it has commenced proceedings to delist the common stock, par value $0.0001 per share, of the Company (ticker symbol: UPH) (the “Common Stock”), from the New York Stock Exchange (“NYSE”), and suspended trading in the Common Stock pending the completion of such proceedings. As a result, effective December 12, 2023, the Common Stock is trading in the over-the-counter market under the symbol “UPHL”. The Company timely filed an appeal of this determination with the NYSE and requested a hearing before the NYSE Regulatory Oversight Committee’s Committee for Review. On January 12, 2024, the NYSE granted the Company’s request for a hearing, which was originally scheduled to occur on April 17, 2024 but is currently being rescheduled to a later date.





Item 1.01Entry into a Material Definitive Agreement.

On April 11, 2024, UpHealth, Inc. (the “Company”) entered into an Intercompany Administrative Services Agreement, dated April 11, 2024 (the “Agreement”), with TTC Healthcare, Inc., a Delaware corporation and a wholly owned indirect subsidiary of the Company (the “Service Recipient”), pursuant to which the Company will continue to provide certain management and administrative support services to the Service Recipient which the Company has historically provided to the Service Recipient, including, among other things, legal, accounting and financial, corporate governance, human resources and compliance services (the “Administrative Services”), in consideration for a monthly fee based on the charges, costs and expenses incurred by the Company in providing the Administrative Services to the Service Recipient (such monthly fee, the “Administrative Services Fee”). The Agreement is effective as of January 1, 2024 and will remain in effect until such time as it has been terminated with respect to all Administrative Services in accordance with its terms (the “Term”).

Pursuant to the terms of the Agreement, on a monthly basis during the Term, the Administrative Services Fee will be estimated in accordance with the arm’s length principle as set forth in the final regulations under Section 482 of the Internal Revenue Code. Within five calendar days following the first day of each month that commences during the Term, the Service Recipient will pay the Administrative Services Fee to the Company as an intercompany cash transfer, or as otherwise mutually agreed by the Company and the Service Recipient; provided, however, that the Administrative Services Fee payable for each month in the four-month period commencing on January 1, 2024 will be paid as a single lump sum within 5 calendar days following the entry into the Agreement. The Administrative Services Fee will be subject to a true-up on a regular basis to be mutually agreed by the Company and the Service Recipient, which shall occur at a minimum at least once in any calendar year.

The Administrative Services to be provided pursuant to the Agreement may be amended at any time by mutual written agreement of the Company and the Service Recipient. In addition, either the Company or the Service Recipient may terminate the Agreement with respect to all, or with respect to one or more, of the Administrative Services upon 30 days prior written notice to the other party. In the event the Agreement is terminated with respect to one or more, but less than all, of the Administrative Services, the Agreement will continue in full force and effect with respect to the remaining Administrative Services provided for therein.

The foregoing description of the Agreement and the transactions contemplated thereby is not complete and is subject to, and qualified in its entirety by reference to, the full text of the Agreement, which is filed with this Current Report on Form 8-K as Exhibit 10.1, and the terms of which are incorporated herein by reference.



Item 9.01
Financial Statements and Exhibits.

(d) Exhibits
Exhibit No.Description
10.1†
104Cover Page Interactive Data File (embedded within the Inline XBRL document)
___________________________
Certain portions of this exhibit (indicated by “[***]”) have been omitted pursuant to Item 601(b)(10)(iv) of Regulation S-K because it is not material and is the type of information that the Company treats as private or confidential. The Company agrees to furnish supplementally an unredacted copy of the exhibit, or any section thereof, to the SEC upon request.



















SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: April 12, 2024                         UPHEALTH, INC.

By:
/s/ Martin S.A. Beck
Name:
Martin S. A. Beck
Title:
Chief Executive Officer

EX-10.1 2 exhibit101-icadministrativ.htm EX-10.1 Document
Exhibit 10.1
Certain portions of this exhibit (indicated by “[***]”) have been omitted pursuant to Item 601(b)(10)(iv) of Regulation S-K because it is not material and is the type of information that the registrant treats as private or confidential.
Intercompany Administrative Services Agreement
This INTERCOMPANY ADMINISTRATIVE SERVICES AGREEMENT (this “Agreement”) is entered into on April 11, 2024 to be effective from January 1, 2024 (the “Effective Date”), by and among UpHealth, Inc., a Delaware corporation (the “Company”) providing services as set forth in Section 1, and TTC Healthcare, Inc., a Delaware corporation and an affiliate of the Company (the “Service Recipient”) receiving such services. Each of the Company and the Service Recipient are sometimes referred to individually herein as a “Party” and collectively as the “Parties”.
WHEREAS, the Service Recipient is a wholly-owned indirect subsidiary of the Company; and
WHEREAS, the Service Recipient wishes to engage the Company to provide certain management and administrative support services on the terms set out herein.
NOW, THEREFORE, in consideration of the mutual covenants and agreements hereinafter set forth and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Company and the Service Recipient hereby agree as follows:
1.Provision of Services.
1.1Agreement to Provide Services. Upon the terms and subject to the conditions contained herein, the Company hereby agrees to provide to the Service Recipient the services (“Administrative Services”) set forth in Section 1.2. Each of the Administrative Services shall be provided and accepted in accordance with the terms, limitations, and conditions set forth herein.
1.2Scope of Services. The Administrative Services provided under this Agreement shall include the following, provided, that such Administrative Services may be amended by mutual written agreement of the Parties:
(a)Legal. Legal services include drafting and reviewing contracts, agreements and other documents, legal consultation and opinions, maintaining corporate books and records, litigation management, public company and regulatory compliance, and structuring and other advice for mergers and acquisitions.
(b)Corporate Governance. Corporate governance services include advice and services of management and the board of directors in support of corporate, transactional and compliance functions and establishment of corporate governance policies.
(c)Tax. Tax services include tax support and tax compliance services as may be necessary to ensure that the Service Recipient complies with applicable tax laws and tax consulting services relating to research and planning.
(d)Accounting and Financial Statements/Periodic Reports. Accounting services include accounting support services to assist in the maintenance of a system of accounting for the Service Recipient and the preparation of audited and unaudited balance sheets, statements of operations and statements of cash flows.
(e)Treasury. Treasury services include managing cash balances, including the investment of excess cash, the credit card program and the relationship with banks and financial advisors.
(f)Financial Planning and Analysis. Financial planning and analysis services include preparation of annual budgets, periodic reforecasts, monthly variance reports and other ad hoc analyses.



(g)Human Resources (“HR”). HR services include advice and establishment of policies for employee compensation and benefits, termination or implementation of compensation and benefits packages and development and implementation of compensation philosophy and goals.
(h)Information Security and Compliance. Information security and compliance services include advice and establishment of policies for privacy and information security, development, implementation and management of compliance programs and support of privacy and information security compliance functions.
(i)Insurance Management. Insurance services include evaluation of insurance needs, policies and risks, management of brokers, placement of coverages, supervision over claims, and support of compliance functions.
1.3Standard of Care. In providing the Administrative Services hereunder, the Company will     exercise the same degree of care as it has historically exercised in providing such services to its affiliates prior to the date hereof.
2.Administrative Services Fee. The Service Recipient shall pay to the Company as an intercompany cash transfer or as otherwise agreed by the Parties, a monthly fee for all charges, costs and expenses incurred by the Company in providing the Administrative Services (the “Administrative Services Fee”). On a monthly basis, the Administrative Services Fee shall be estimated in accordance with the arm’s length principle as set forth in the final regulations under the Internal Revenue Code Section 482. The Administrative Services Fee shall be trued-up on a regular basis mutually agreed by the Parties, which shall occur at a minimum at least once in any calendar year. The first four monthly payments of the Administrative Services Fee for the four-month period that commences on the Effective Date shall be made as a single lump sum no later than 5 calendar days following the date hereof, and each monthly payment of the Administrative Services Fee thereafter shall be made no later than 5 calendar days following the first day of each month that commences during the Term (as defined below).
3.Authority. Each Party warrants to the other Party that: (a) it has the requisite corporate authority to enter into and perform this Agreement; (b) its execution, delivery, and performance of this Agreement have been duly authorized by all requisite corporate action on its behalf; (c) this Agreement is enforceable against it; and (d) it has obtained all consents or approvals of governmental authorities that are conditions to its entering into this Agreement.
4.Taxes.
4.1Sales Tax. The Service Recipient will be liable for and will reimburse the Company or pay, as applicable, any applicable sales, value added or similar taxes with respect to the Administrative Services provided pursuant to this Agreement. The Service Recipient will not be responsible for any other taxes, assessment, duties, permits, tariffs, fees or other charges of any kind, including, but not limited to, taxes based on the Company’s income or equity and withholding taxes imposed on the Company.
4.2Withholding Tax. If the Service Recipient is required to withhold from any amount owed to the Company for which the Company is responsible, the amount withheld shall be subtracted from the amount owed by the Service Recipient and the Company will receive the amount remaining after the tax withheld.
5.Accounting. The Company shall maintain accounting records of all services rendered pursuant to this Agreement and such additional information as the Service Recipient may reasonably request for purposes of their internal bookkeeping and accounting operations.
6.Indemnification. The Service Recipient shall indemnify, defend, and hold harmless the Company, its affiliates, officers, directors, employees, agents, and representatives from and against any and all losses, liabilities, claims, damages, actions, fines, penalties, expenses or costs (including court costs and reasonable attorneys’ fees)
2


(“Losses”) suffered or incurred by the Company relating to any claim of a third party arising from or in connection with the Company’s performance or non-performance of any covenant, agreement or obligation of the Company hereunder, other than by reason of the Company’s gross negligence, willful misconduct or bad faith. This Section 6 shall survive any termination or expiration of this Agreement.
7.Limitation of Liability. Notwithstanding any other provision of this Agreement and except for liability caused by the Company’s gross negligence, willful misconduct or bad faith, (i) no Party nor their respective directors, officers, employees, and agents, will have any liability to any other Party, or their respective directors, officers, employees and agents, whether based on contract, warranty, tort, strict liability, or any other theory, for any indirect, incidental, consequential, or special damages, and (ii) the Company, as a result of providing an Administrative Service pursuant to this Agreement, shall not be liable to any other Party for more than the cost of the Administrative Services related to the claim or damages.
8.Term and Termination.
8.1Term of Services. This Agreement shall remain in effect until such time as it has been terminated as to all Administrative Services in accordance with Section 8.2 below (the “Term”).
8.2Termination. Either Party may terminate this Agreement at any time, either with respect to all, or with respect to one or more, of the Administrative Services provided hereunder by providing at least 30 days prior notice to the other Party. In the event of any termination with respect to one or more, but less than all, of the Administrative Services, this Agreement shall continue in full force and effect with respect to any Administrative Services not terminated in accordance with this Section 8.2.
9.General Provisions.
9.1Assignment. The Service Recipient shall not assign or transfer its rights and obligations hereunder in whole or in part without the prior written consent of the Company.
9.2Successor and Assigns. This Agreement is binding on and inures to the benefit of the Parties to this Agreement and their respective permitted successors and permitted assigns.
9.3Amendments. No amendment to this Agreement shall be effective unless it is in writing and signed by the Company and the Service Recipient to be bound by the proposed amendment.
9.4No Third-Party Beneficiaries. Except for the right of the Company’s affiliates, officers, directors, employees, agents and representatives to enforce their rights to indemnification under Section 6, this Agreement benefits solely the Parties to this Agreement and their respective permitted successors and assigns and nothing in this Agreement, express or implied, confers on any other person any legal or equitable right, benefit or remedy of any nature whatsoever under or by reason of this Agreement.
9.5Cooperation. The Service Recipient will provide all information that the Company reasonably requests for performance of services pursuant to this Agreement, and the Service Recipient will cooperate with any reasonable request of the Company in connection with the performance of services pursuant to this Agreement.
9.6Counterparts. This Agreement may be executed in counterparts, each of which is deemed an original, but all of which together are deemed to be one and the same instrument.
9.7Severability. If any term or provision of this Agreement is determined to be invalid, illegal or unenforceable in any jurisdiction, such invalidity, illegality or unenforceability shall not affect any other term
3


or provision of this Agreement or invalidate or render unenforceable such term or provision in any other jurisdiction.
9.8Governing Law. This Agreement, including all exhibits, schedules, attachments and appendices hereto, and all matters arising out of or relating to this Agreement, are and shall be governed by, and construed in accordance with, the laws of the State of Delaware, without regard to the conflict of laws provisions thereof to the extent such principles or rules would require or permit the application of the laws of any jurisdiction other than those of the State of Delaware.
9.9Waiver. Except as otherwise set forth in this Agreement, no failure to exercise, or delay in exercising, any rights, remedy, power or privilege arising from this Agreement shall operate or be construed as a waiver thereof, nor shall any single or partial exercise of any right, remedy, power or privilege hereunder preclude any other or further exercise thereof or the exercise of any other right, remedy, power or privilege.
9.10Notices. All correspondence or notices required or permitted to be given under this Agreement shall be in writing, in English and addressed to the other Party at its address set out below (or to any other address that the receiving Party may designate from time to time). Each Party shall deliver all Notices by personal delivery, nationally recognized overnight courier (with all fees prepaid), e-mail (with confirmation of transmission) or certified or registered mail (in each case, return receipt requested, postage prepaid). Except as otherwise provided in this Agreement, a Notice is effective only (a) upon receipt by the receiving party and (b) if the party giving the Notice has complied with the requirements of this Section 9.10. Such communications must be sent to the respective parties at the following addresses (or at such other address for a party as shall be specified in a notice given in accordance with this Section 9.10):
If to the Company:
14000 S. Military Trail, Suite 203
Delray Beach, FL 33484
E-mail: [***]
Attention: Jay W. Jennings
If to the Service Recipient:
14000 S. Military Trail, Suite 203
Delray Beach, FL 33484
E-mail: [***]
Attention: Martin S.A. Beck
9.11Entire Agreement. This Agreement, including and together with any related exhibits, schedules, attachments and appendices, constitutes the sole and entire agreement of the Company and the Service Recipient with respect to the subject matter contained herein, and supersedes all prior and contemporaneous understandings, agreements, representations and warranties, both written and oral, regarding such subject matter.
(signature page follows)
4


IN WITNESS WHEREOF, the Parties hereto have executed this Agreement as of the date set forth above.

UPHEALTH, INC.

By: /s/ Jay W. Jennings            
Name: Jay W. Jennings
Title: Chief Financial Officer


TTC HEALTHCARE, INC.

By: /s/ Martin S.A. Beck        
Name: Martin S.A. Beck
Title: Chief Executive Officer

EX-101.SCH 3 uph-20240411.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 uph-20240411_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Security Exchange Name Security Exchange Name Title of 12(b) Security Title of 12(b) Security Written Communications Written Communications Local Phone Number Local Phone Number Trading Symbol Trading Symbol Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Address, State or Province Entity Address, State or Province Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Document Period End Date Document Period End Date Cover [Abstract] Entity Emerging Growth Company Entity Emerging Growth Company Pre-commencement Tender Offer Pre-commencement Tender Offer Soliciting Material Soliciting Material City Area Code City Area Code Entity Address, Postal Zip Code Entity Address, Postal Zip Code Document Type Document Type Amendment Flag Amendment Flag Entity Central Index Key Entity Central Index Key Entity Ex Transition Period Entity Ex Transition Period Entity File Number Entity File Number Entity Address, City or Town Entity Address, City or Town Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Entity Registrant Name Entity Registrant Name EX-101.PRE 5 uph-20240411_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 7 R1.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Cover
Apr. 11, 2024
Cover [Abstract]  
Document Type 8-K
Document Period End Date Apr. 11, 2024
Entity Registrant Name UpHealth, Inc.
Entity Incorporation, State or Country Code DE
Entity File Number 001-38924
Entity Tax Identification Number 83-3838045
Entity Address, Address Line One 14000 S. Military Trail
Entity Address, Address Line Two Suite 203
Entity Address, City or Town Delray Beach
Entity Address, State or Province FL
Entity Address, Postal Zip Code 33484
City Area Code 888
Local Phone Number 424-3646
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.0001 per share
Trading Symbol UPH(1)
Security Exchange Name NYSE
Entity Emerging Growth Company true
Entity Ex Transition Period false
Entity Central Index Key 0001770141
Amendment Flag false
EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.u1 html 1 24 1 false 0 0 false 0 false false R1.htm 0000001 - Document - Cover Sheet http://uphealthinc.com/role/Cover Cover Cover 1 false false All Reports Book All Reports uph-20240411.htm uph-20240411.xsd uph-20240411_lab.xml uph-20240411_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "uph-20240411.htm": { "nsprefix": "uph", "nsuri": "http://uphealthinc.com/20240411", "dts": { "inline": { "local": [ "uph-20240411.htm" ] }, "schema": { "local": [ "uph-20240411.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "labelLink": { "local": [ "uph-20240411_lab.xml" ] }, "presentationLink": { "local": [ "uph-20240411_pre.xml" ] } }, "keyStandard": 24, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 25, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 24 }, "report": { "R1": { "role": "http://uphealthinc.com/role/Cover", "longName": "0000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "uph-20240411.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "uph-20240411.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://uphealthinc.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://uphealthinc.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://uphealthinc.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://uphealthinc.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://uphealthinc.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://uphealthinc.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line Two", "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://uphealthinc.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://uphealthinc.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://uphealthinc.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://uphealthinc.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://uphealthinc.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://uphealthinc.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Ex Transition Period", "label": "Entity Ex Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r7" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://uphealthinc.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://uphealthinc.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://uphealthinc.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://uphealthinc.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://uphealthinc.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://uphealthinc.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Issuer Tender Offer", "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://uphealthinc.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Tender Offer", "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://uphealthinc.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://uphealthinc.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://uphealthinc.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Soliciting Material", "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://uphealthinc.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://uphealthinc.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Written Communications", "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 15 0001770141-24-000052-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001770141-24-000052-xbrl.zip M4$L#!!0 ( &B C%CIB<\[NAD ,.W > 97AH:6)I=#$P,2UI8V%D M;6EN:7-TL!1U&FBLN VQ$,QFUZ?04P MX]A/$RDI596-KLF4*&K^^GU'ZJ@;N[M=*N..&0,Z,E.I=[_?>WHUS./H]:NA MDL'K_WKUWSL[XDWJ%[%*BIT==]5YFHV-'@QST=_M M[XLOJ;G5=Y+/YSJ/U.MRG%P>^ M/%!JWSOVO%Y___CEH>P',@QW#\-_]9[ K7 YWV/S<:1^>1+K9&>H:DT [@Z3[.30[@L5_?YCHST(#FA]4L8[&)W^[T;&RXJ,:B:LTELG? M.E8F=LBM]OMO7J! MU\][_(7/]'MA'O=.GS]_#C_W3NE8[W1;#.6=$IY2B4AC MG>,=66%L(6$#\E1[O:7OMG&R*S4H(HESB^N=_X7;?5E8 M)6!F6$22YB*&N8V6D9!)@,?RH1+Y.%-XLT["U,1\=SZ4.9TT:J!M;FA:Y!TK MI!69 ;[(X28C_#0)=0 L 8-V)]_MHC?LI7F>QK!EL,N+7[H/8RHS]<[_^*OM M/8A@+W%N/XTSF8S%60"<29N0:W@GU\K<:1_F.AL8I5@:?"M)\R$@"ACE9 ^N M^=.?=YI!YQ/N#1+IY<>;BZOS3Q\^GWW\/W'VYL/EQ\OKFZNSF\M_7HCKBZM_ M7IY?7(NS7Z\N+CYJ$B.I%$@FPQ(8A9H;=G/X DH>F7PJB>OKY$D MX:7VUKF-'2+"FYMSP03H \FM($*B6O@1ACK2I$!#4K*.*%I#I$[%@3GAZTRW M1;(:Y2M]1^1:^,.*9KOB0L*?4UN)6XU_SSR*P)=BTUCEM$BC0F506(-41N,, M&**043060Q#AP # $+(-K^2S-'D;I 9M+,P9L5: C9)L1;9DC[2R+=BE[D:; MA.1N?GEW<75Q=MU9P$4:^6(T!$(8[Z2CA*R=0 .+PD(+SX):06MFDBF?/3TX M)@)ZR.Z0>]#*[>D_8'M&V@YA,A J*AG(@9J037"452]H!^E.V#=CL@0]JEAUN!%\)M(80@C!FD:T*$[ M&172B]3D5!WG!8/JR?C=V +4MP]OV2?Z'@TU:!]4*C@;FJ;^;9*.(A4,5-!Y MH$XJ;\6EHT -@:_2D06&>7FZZGTN<*[!P=K>&0%8IZ)9R>9+HBP3SPXT\ !%U'_9?;E&0EFC MH3^Y6\?=WG)"J8(1*.4_.RG?"H(1X"I/Z T69M[OJ+-AL7@"1%^@.70)OZ)F M L7.4G12E#4%EFTJ-#?0K(C#HY7^VFJ!M;@@K-<"ZW%[HWSP;G_-9-UT_Q;% M:NT0G#H,NSDZ994O?5]E.=FN^'MJ ID T8XT;'S%)QT1Z5CGM &VX_R?BDWJ M-^7,+R$>E61>X\O_2LE\[:>[!"HY_KP8R6C.7TQIJPZ=DVL" M5XJA3%0G1MUIA=Q+1I>1?HYZIG9C\1IV5@.'/T"E1 .CKUI$>1U>3C.@;U)4 M,5AO:,'QN!R$5L)+TUOK9D6%1^HMUP,>H0Y#=$16>,#CPF\XKX;3RZD9T^%( MH[IDE0@L5?AY8")F@%$6"0^6X-X0ME< N?88:DM_'GKSM(( M@TB/B?S]UI#_ W3'C;Q?MWTH[V>I.\>#CD*)CN'O!B4V\[C.I$D4_&TQ&$_! M:%L85:-[9MUT'@Q&("=(9O"'3U%1G"F2(]N8EE3/1/K8*$0?P1&8RRBKI/$Y MWII%,D%-](C(/6@-N:^6]F?@_!9)99"\U2BD$"9V#:8%6R'/GNX?G7Z&Q:0! M6 57"DEPW2Y48]FS>J!Q;CI] M0IK04W 4^)1+05E(LF4%B2V''%A%V^'L] M#IHQ"W+*3J5D1F6RSE'((M"YBS442?F7)R-FUJ%2:,G9:H_Q'G!2>0 7H)LX MZ4L[%"&F!AX1(ZG6,-)#](91$F3L6E/UJ#S<,F;Y@@PA\@F0EAPMVHX[3[(; M"%DG=V#'E!:,ND<=0G=P&-@W"F@9#H !!2[^P,BXX@'6 4"_0YVQ%O%DXGR. ML!(L:*99,+D>$1V'[:'C7O=P!1W7*N"S4]WT L_ _!V#Y%PS>=>KRYJKDVYU MLU0_+9B3!(,[7A$,2 1GI5XS"H2\ D+'HS$L91B-Q9TT;%X9UGH3#JX8IKZ; M>)DU[Y[@",DX2]GW/6%6N5,+>AL M_G=HRKLS<))V/! >MSN4-C^1T4B.[9,_IU!AU6I^9.X?M(;[5YN#[PJ8$,P; MFQ:F'>FZI:N]:F>&K,SFK5E6OKM:&B29"5>4D0DR=Q5X@^E8*?(+P7NL XV> M2E2H44QBE@SD,7#8JBZZ57QB=\TL[KT(7:V:2Y@IMF"1_O:H0O'1^X13GKNT1S5+'+55/.C5\^(O;1K6&?7K_; M.UK%/^#+T:OZ4-'!VAFF7-(,6RA"4I8R6U<7)DIANJGB#,HH:7M+N:HF>7LF MO54&+XVDWR#Z.V506720SG%2QN/!4>%'4L<.G#$1P)]#XW\)/J,=8(R]MM#T M:C!&#J_*I5_.I5F_^&\40RW#$2'(AQYC$@XWTE$DGCWM'6(U[_2_ZEX97UM& M:E@9*Y#V!/2E@)XAP*_.Q1!^#&'*U&B?*E#*^PB>U*C5:A:_4-D*>J1E21$5 MYV*N)D;V6:L42;')4558'84 MX%CB6A=*4T21,J4AR&0@0KB&PB0CI'X"-!"TI@&?P5*Y,LP2*D8*X(3^$ @0 M3_NI=0$7=8^V/^N9@DJVW%#EBO1#F;@M978MI872;^V*3TGC]7C2:MM9NK&P M\!II"2:QCN42=*4T,4[5.SJU(E+) Z#[$J \B(U4XA**#>-R7=3]3BP%3Q. M":K8Q]-78$DG!5(% :\9I+K_LM]="KB;6'EN"A7L%!F6V4@WG^'G=["P:+R( MG+D82RRUOFZQ"L"#]@JO8 A4!.YEQIWESF>^>PA?7K6>" B4= MK^(_+.V0[>:NE24M_ ]G]A3P9^A6XV]/ST!-,F %OB)LB1Q(U'.5*&09@-QG,6@0G@(*7T8D$QE<16&3J-HY]#.)L;D4OX+M.[.9]A39 MG+9U@%..$H[\ M&I!J=-@H'7N%L9-5X1@GEBB?;0-VUR$#L0'#L_C4'2I6Q@ T%BO C5;#LX&Y MDR.WL(5ME,T:E7TK*TV:W<6F!.'29\2N8IZBZ;!NNG[8L=-[M"9\+/#=+ >X M@X*-Y0PS1Y1"DK#[(?P28CEA59OMO$#.V(_%+;!( ZC2$5Z1T_Q4H$4]/#IN M"\!8QYU))ML/.&<#1DACZEZ&>LP%^G'3AFG$SB.-H>,LG1WEDN7"I?AXL899#ZYGC,EV7$7,&+V&/&&(AWQ!4T1@8S%#N9$W,,VN8\]=#<( MC:Y@],I=LH5'%2;*S=BXF&9T_NQBB.-$R)-;\JCF*$;%KNB$'36JHY3WU5)^ M7+/J8(/,JAHYVP+M69(4$VE9M]1$WKI:)5($4=3$F^,C+=5>+B>$./2 K7\9 M361$G?\U2_$(H$<8)=SA16/B6D5!&8/3H6XH8S':<" 4A\8"JUNEL@J35C]% M#>W]9B72?BXXW" NN(1?XT2'V)(53K6 %18%X+5;*4$%0H5V$!(7:0XPDN(( M\;D-\=R9R@IU@%+A,2FK6I4[=2IX#]4;2,+4#$D*!S@$).HL76&'1F/VXLY:TT0S#4TM5V0)ON! * +Y."ZT"0M M2":])S9L0]Z(.F215D8TX()D7;-2C'(@*#"X]@;T-Y854+@4_$+JU$X2B(;# M*%[BTCI5*FG:PYN(;QKP$9.=J9 GS>GZAG6:U?W@>WI160\]U52RD?UWOBVF M&[S23)AI=^=6,S#P;D2B!C"NHHII-)[# FP=;3$H6?@TL2?!*)?P3*0,P(AI M)ZZU3*H=KI/8G%ZT!>C+.T6O._MA MW8F+75US3UR))C$KXX'/6RW9BN9&ZZHBOGVMR MJJ&BT:K87-GMHE-FS& .&"K'DDBC_;Q>#LW=""D.58JIK#+06+8>I> @?8U M1AW.%('/1M\FH!%PU5@T5%NEF&C2>GO2=*:$-SQC$3DH;0DJ 6$_/XZZQ/_L M.$GEXJ0N'CR[O=PD(^7J[,1U8[,KT^*D1^M(D5.CIGS$'U?0O=P@04< NH6 M7JNHGSFM[T8HFY/3(D)I4XNR.7W'.,"+ECA_PD)@="OB$!OV5&_ 60E#4)IE MF+_GTGL89)$XFP,5:[<1_'*][0\9BM0:1"/2;QMM%/@-\JT5^D]< MZ(;IA9'^2DS-6/8<[D31!I8MWS:=80>11@;F]/$TH?@#FG6=599\05;?=>%C_R@'@612;IEK"W]XFN.]KN(>3!:C*@B_ZU@QU?QY =ID M)DC*.$>T5VRY%;;$X;L3S#=_7@7^1I#PYM0KGV%C<"J_6GMV@IN4EY\8F6MR M3WQ>M$C(BN=O *.8Q;((!TY"FIO-S2[^3A%_NM3#CRZ7-X&#PC#9:EF/BX;W M-X:&@71N,+6^PT[OWTFD^5J:-7\S#[WQ.G-&M5!X=E$V_>M!37,Q3511Q:ZH MD]=LHO!W()NP,%=EVFJ7.RJ.AS&VJL!<)4TMJIG$A<_$'[2*F-=)X8_)'H38.-D9MG*<5;GGM-OO" M*J3R\V.,E:W!W56G\QIW-@WH=BVZ)N%A%<)\66)_L9U$:_+=QKFXY,3LJH*3 M3T',%@# NA!A,2GH2>S.P6D#:GY17I>G \;]8 FVNX/]"$PWE#Q$?9$06VZ* MQT>]1QM#O==HXK0#IW=9Y[.H=G8).(](E;-&%?'IY [H >M)H\KL*Y)F5P+7 MG>7WPF@;:)_[*!#,P=U+P#1W.V+F)D=@'%TC,LK)K@:*#5?^LUIA40^2'ZA: MX>%2:4TB: 7_4$R>2!ZM&?*!R,F9Y!=& ,VPHVXZ6TUF>EPR_N7&R'C^X!>Z MU>_EJ%4F2O,K%2A6U?U0>]1 P/I#%134&D'F.=@I]9?S9)8!M5;=&[%'0%FZ M!DY"3M^DW<08_:O!@L2:C677*6BS4N66"=+\^,1\7\_9VV\*]^ZM3.GD+8.)G%.PRW(0D4%719>XJ5%RWDTK+Y)43 M-@"&299]Y)HI?7 7:1.=? \S4D3U"E.L T MMTBN>:"\K H8;'0!Y\:[G'ID:[DT1 MI),2#C)J].1C/";U%<56%X.$NNVQ'8:I,*R"US#2%D<2$42I"#*J,JF#[8Y0 M.S'(0W<>[01=1D!1(2,2)]86+85MJK)7((!"S>\$; QM'G1[_;T'#?N" MELS+AHVQF4Q^>;+WI YLT>:>]+-[ 3: P)][W:.C2>,)MWYFF]+L^UM.%$B[ MK+S/"K+1)">W(ZL?]F%/^$#"['>/#AK'R-1U!]?UF0XXO"NNN^(#1HCQP\PW M!O1N!P0K=M3M[^XMY,"6/QGX^D8BL BLAXYX^U[L[>V_W,?HZ069)]SW^-G3 MX][I\^?/X>?>*9X\0T@OUT7@^=]@B"]=\9NB[SK:J<#K#\\[,\GD-7 1^7$M M)[:?;+2FY&.E;W\!+].HVEUJ M;R0>4_AEDK\!=>'&%%\9H^>V';G.BUQQ1SN$$'*U(&](HU?3)'1F&1QGMB&R M+;S?\4_. 5"5(C>9QXB93JIOB8&SK@+T70AEI%T1 UZN8FQ]GZBTV M2/N+R9=&/ %%$&G_ R##O0-?'BBU[QU[7J^_?_SR4/8#&8:[A^&_]I_\FT+ZVOQY=W%U<6GMYT):#?G5[F=5 4CFP9[5WE/ A/4:1[I MI7>K,PTKH1D/]0L/^M_!#)G?)>,?G]]=G+V_>=<1EQ_/'RS)%RZ_[9LPGY;^ MSN&!EH;DGCW=/SJU].^T0[KH,X]?^^_&O;&/,E8/<-$WX$EN=!ZY1SD?:A6* MMSJ1";6&^\051=^5*3>$CQ>T_+DY%RS.SL^N+GZ*M(T0:=/!@4Q"K+U_WKI<$8?@SS.'K]_U!+ P04 " !H@(Q8 MLI?,'T,6 #TE@ $ '5P:"TR,#(T,#0Q,2YH=&WM/6ESV[B2W^=78#6[ M+_:42/&2=3CQ*X_BS'B3."G;J9FW6UNO(!*2,*%(#DC:UOSZ[09 ZKX1V]>V:;UBK#(CP,>]=^\.KWJG)^_^N?) M#Z__PS!^__GR WD;^_F011GI"$8S%I!;G@U(-F#DMUA\Y3>4? YIUHO%T##4 M8YTX&0G>'V3$L1RON*VX*MI'C6;3J@>.40^Z+<,[JM>-%OQI]!JM@'5[+>^H M%U3[;=9M!2W'J1MUW^H:GNO:!K7@-I\U_."HWNU2FU6#=D#]AM>S?+ONMCPW M:'2M1J].[?3@29QWD ', '>4MOE=9J3,?U,99%G2KM5N;V]-^&SVXYL: MCT(>,02[E@D:I0@5S0!/-<>RZX;5-%R[HL>Y@UN_3HURZYJQZ-?L5JM5DU?+ M6U.^Z$;'LNS:[Q\_7/D#-J0&C]*,1CZKC!\5U"#X/P%6N8A3M@X[OEG<7NP 6$ MT)4WMD,*]%IAD?'EJG+R>L!H53AQE0+O&]2B!\7WU MZ4TE8W=93:ZQ=O+##S^\SG@6LI,\&1A(L99GVZ]KZKO7-35R-PY&)Z\#?D/2 M;!2R-Y6 ITE(1^THCAC,S^_:>",3ZD\>!"R2?\+U"^ ?P7TU_5UVR7IO*KX! MA!31(8[$>/LL@NE&'5B#>Y63'@U3-C=N;1H0P7I,@*!@Z0+T(QVU4TG',#.1U-_. M .EO*BD?)B%NKOQN('!ADY@V[]( MD%.-YY#3YG&N9"?)!&U-7!RZ0A<\3V3 MZ"L^\0 _]S@31"Z)+>3USOG[:;3./GQ2?#4]>@+8B8/B$Y"NR-Z"7#Q!> S+ M,^QRJ/&UIG[30?PGBC8SUH%B=MQVS [ BS04/>C]H^; (3>HIB M%#\.8]'^T9(_QSU DM&C0QZ.VJ^N^1 (]8+=DLMX2*-7U10$)$_=F/*_ M6-OV8!;Y\58!W8!Q4,B52' 0\B\7Y]=G;\G5]>GUV=4T9!,P[?+IX0!&[3Y4>RN< N3"^EO92\!K9M&N_G MA?7^[JCM .1 DI=G%]?D\NSSI\MKLL_KE3OU.1=I3L'JS6)RQ7RTKHCMDE@0 MNWX0')*X)TU@N)0+GG&8^.S.'X!.9.34S_"RW7*][>%<)#V74KK[**2]&<*V MI^K/4L>=*>2;>T0@UD9X.#B[ ^M( M@HMT(4HP"4U)FC ?K=2 \(CP+"4@?(!,Q%HR&2M) "NCW9 5-W1C 8:D >"% M-$E9N_CCN'!UE/]GR(>.IX>K T0W3&3=.)C6%^A-H+>5L43$-SC.6%& >_N6 MA?26B@4>[A)6V1_4SIJ5WF))(;&#QDD,1HD@?X!-D@9<62W?#93_^-$^LHY! M$O))PI!0BSZ-^%_R\XP K&7!8S%@?1'^ZL^8 =_QD,'-75BP9J8Z1DQLPVVV MMC"X]@=/&W)3)QX.>8KA\>\&)L4[N*%$[>@+F^R,3:[IW;D.&OI2!$WSS!$X M["ZPC-NTO/K&3+,HP':\/ZA<3W6(R8-S\]*\,LG9, GC$1/?-[2*QZ9)806W M2?.P)HWIU4Z=;9G-)[#6;0OV005^MS'7'3!_76\G-K;7-!N-HYT,9==-S]N- M$V';IN,U=F'Y6RA/]3C?+GC5YJT/T^^%G+V/GW\:!(*EJ?[U <:S"QG;J)S8 MP)06 6'SD8<\HV)$K@7EX:S K6X1?ETVK5-,VZR<7.4<+&_'D,HZ\.$,>;"N*ZWK-VN+8 MZ4R/0$*MOXU<.]A<$J L.Q6,3O&^ VY)LSG+^8=;")@/,:#O\R".9H($MELY M\1S/<(^\H]7^SC;4O#?:;LHM\4RW,>>6Z"_WP"V1A#+.C[Q*2<9"EN">D4AN MVJ2XH4 C2MZ\R/\'B"M.8P#FQ)-"JN]>(0)L?G,./#,5:;DH-B-QX(3W+$-CB7(? 92 S,P>:1C MJ.ET;5"/W[' D"7+I<7I8?2UU?"\XV\V.'>5YEBP):VR1O:Q-T"C%>">Q"M) M)HK<+G/@8,^I:UD[4]R&-6T'=H-TWET2Q[5,N'%I3/N%[+X&V/@BL\0?-359PEQ7L@U^6=+T2_.Z+_ M+!C*>3SN(8N$<= \W8P5U M[PLS/!@SG*=ISL16+-%X88D=LX3+#._ WXPE7#">X-Y[)_JGW*G'1@]&IR:, M/>5X,P&N>[+H&(24$]H1!T2T]]E5]$S+V;J&P3TRO?IVU0++OW<;.ZHX=LU& M:SL']N$7Y=9-UUH]U&XUPMJ(XQ,JAO!<6U/<."S<7PJ&*RJ]&P"]O[0A_?S'47^A2-9#I6J/'OI2!Q,0V! MKKX=<(!WK-"WM]BUBI:%B$E&4O"J X)+/UY!18NS;\I>W.^27FT&C6RG*P5U M:5XW*R=HH -.K[+8_UHE"17DAH8Y(_\I"R5MDF##@<&J@R;?S+GWVHV-;/>- MBQTV1J46R4J&E7AL/1$)?/G\ZX-D8\!4;&RP@.,D3CF:SVW!0HH%/\>XB89K M>LUY0Q9;LN (6.;Q,(NN?].:%]C>XR7;SQ'/8\=MEG5WI'/_IG*T\)C5T=S9 M,WNHB*>/ZSD6Z&I8[+]B\55)VM+I7BE5-ZZFKZ,O\$0AB/,HP' #(]T1\65> M'1;V%90TD\?V9I+>/"6P1 ; ]C&(W1?Q;3; J$6"B7":DH#U8 IY EAE;ZSZ M@KX$XW8$+CE L[)Q+#,XQQP4@V(89/S W:CD8^)).K[>!89;\;F90$50:I*48)E43/W@)91LTD^,LG61=UG=]6W!,T_)6%2TO@VW9+.2!Y$;=;*XU4NU5!I^] MTDK]]_8_^X6,.;ZQG7LCX\ ^?!"CO;7!FBLGGR+REOD,RY&+=CYNE4QW;R$' M*#?_\6/3<:SC3J%QX9-]? CRV6< :T!N=9T+"'[N,](3\5#*6Y#1O1X*WXM_ M79V12];/0U5JF TH&%I*:Q3)H0 %N<\8&N4IBO L)1FE.]PFX(\>S@)51A<*R*IC$)88Q6A]R<<1LO%CH))(FJ=)J>]D M@3>/BB65,Q&\!:]IZ)*0%368:>X/)E%ADE.P2 '9:1YF5<)Z/51M-VQB\YQB M\^:F 7-P9A7Q#;I# TS*Y>CE2(7.LHELFT)5@1] V <-H$FN)S"; 2F&(ZPC M!5"!>&F2 .&45FC 8/ A:&X)5]F\5E("HDFP/W.6HKE R8!1@4OL,E"G;'R? MIIA8C,@GV3D7B%?"A^3&<%5VXS@=?R/MB4NP&MBM28"\_YM&.1Y)U CRJN.A M^VBUX!Z-(2K'TTN3HY6+J^J@WBV0; P&,D 68DDM6$5!'JIRV]@'DYU@O:?J MD=50TY)N+MT*N"C LX2GN@S!A2V=?)J2$ MF"':D6FZ[3[:)G!<[RQI'%MIG M_ CM@B^<9_./K&LGJ?X?B+$CWF=&5S#ZU: ]6'^;AK=TE*)+_H@=+E=JSS47 M'[T=4PM;&&V7&[5MTVONYGQW\\AT[=7GNQ^BG.21 R=2Q9UG;$@ #_86H>"] M!^H,FS%AF3^*C*)P$;0!N$E<*H;3OF"RUL+<(%:S)V;G>O^DL%FF^P^N-%@> MYQS DLZ;2JD\T5$$N8324)/A3!FQ0IJ) %'PN8AHG08@FZ4;+XGGBHD;/! [ MIJ*JU$C!#.+W!M'E.ORDA=80!>LB M1GLBOE6AQ8"#=9V!,=A-><#1B)DS;/<#_9I>P.SR><+W9ALF8T'*<)M$WBT/ M0QGOX1%X$7"+CB$1'X0\!4L95@)FC:Q7D]LSS2-IGLCFH6G!*S"""MG.X&+! MU.CR@'T,1BTJ$]CQ,GRU;)")LZ) 0V#;]W6_N0R;-:=5$K(^#:N3P3%<"2XX%T+B<6I3RB_=U<\N[)3O--;;!R?4M5@]['A:UC-?NSG_4YA[HTA/-DH'?=6;7-1'3PVW="^ M*!D>)!!&9G)1"!#2+A?0FCRJ+(9E$"5D43\;%"U7 M0DGE*9-!%:3,2!]"CB@R2!$83'48JLC>>,TR'2IM5KS[$AMTYR@5 V:2WSAJ M01@(%@WZE&%.".S543IQ5EG-)-(,+Y35:!(I*A)9A""7X&:!6D>,)'2T%G5Z M=SKC[#&-Y GMTOSV:3I0F;$>MH5 K9$J_7[+4T:&>99+,X'BGLZI!!0R"Y=X M7-H5H.CC6\"9J"I@URT9P)+Q$%1@$X@J=@R,!=4BOLCA:>3)P^31G!0L:">A M/)#@XVG^/@P?YL,$9.!04@\,7E^Y?6SL\TX1N);+&Q O6-)_%%*48#[7R!/% M'8K\A.8.N-Z]/]J+*&$Z0%&MXH& 2HV>_QSXP\/4PGDA8+$-9 MG@"1NI9B"I"F.-QTND4C3_D$"1792((GV4:^RV!ZD3Q=96%,+0WCUB'VS@+! M$6EH5JZV.H>023\+Y70.7X!D@65+DU<91+.+4+4%:#4A_R_#3$E&/;59@O'( M).2Y:_9K*65!*,4(?,!27_!DLD''&+T%?4OU07VE0649 WAQ5*!6O8MDR[.@:PL&[4J!A!&7Q=I/$D:HS69QGCH(Z7[C8]W94&8[.*) M D>%4+3T2,T%B+I'^N/Q%8#L6!D?,YVCNK<%42W M],"#-7'F83<4N?YLQ?.FU<7V.5JF,HSH'3\*K>ZUOK8W0MEK6LPX]0):IKA^ M!\7-FRQ#H2-@OLZ[JE=($_5F9+T4V[(-0/.DPVD.LB$>(?GVC'D5_1.T4KHL MN\5 _TSE EY:E#A^7:.+>HE\5RSE?6]B?S/&Z& ZEGRF?1W?IKJRDV:4R+<& M'6"%9Q!H!UK'8,^EX4;PC? DT&_U//Q&M?$8MLK#]%/=#-,[JR]_9!O;,>ON MUC:V!Z[B;E[@TG+-QAIK_?G5"JY(#6ZETY^#:.WH@A:,M.2B. M>,DDATX1_^]//_WT?V7YV(""3)*IZ5C664\'[F5PXLBR#[J'![9U>,!O#M7[ M=>KD M3V0Y3NA5-0JQ1.1/!(LH/+PFA\G M9:V5QI'*RL%0J4Y+RJAJW*N6A19G'16GUY7CF]1=/I=@Y,MS+\\]A^=>SD7, M+VFWV_&D[UVY.O_EXO3ZR^79UBM]!GD_U2AQ)AF.NH0+'=S>K"= 5598J)QY M==$)[2 /L=H@3V5JD*?Z?0HZ+Y\"$E2%(J;^NFQ PUY1^2#KF'ZU^K MY/RB<\^RE+E>E(OZ3#RN3^5YIN,VMLY;N*;3V,VK+)N>67=V\BK+W?3S7="X ML5%_LFXM/X_:"Z)=&^&!X&]G/3X>Z7U$B_N8U-(:^4AA/> 8F:X_MBC;?_8U[.ST+NBAI@KP0Q7SGUN];)G0&G/7 I"M>2OE)OI12D"WB M"'OB_]2Z<3""7X-L&)[\/U!+ P04 " !H@(Q8C]66@&P" !J!P $ M '5P:"TR,#(T,#0Q,2YX'F>R04"352HM%:5)K&+NE;K MV^38)\2J8V>V4^B_GV/(@+:L0]K#>.'DG.\[]Y.<7ZQK@1Y!&Z[D+(B'48! M4L6X7,Z"N]MK?!9#\W<8WW^X6: K1=L:I$67&H@%AE;<5LA6@+XK_< ? M"?HJB"V5KC&>>]JE:IXT7U86)5$R[F&]5>>3Z=E9E+($IZS(\'B2ICAS(BZG M&8.BS,:3DKU?YE!D+$N2%*6BPQ0HN'P[0ZT*+'C\*.W-! M#/3PMJE^HYT,1-B*2SJDJ@Z[8J-Q' >(6*MYT5JX=EVY@I*TPLZ"5OYLB> E M!^9:+J!KZ@%@SVR)7H+]3&HP#:'P=LSY *&N$;QNE+9(OF#N=2+.LBQ<=Z4% M:-.XA:+$^GTXV@F/QYV(XP2/XN':L"#\J["'CK@TED@*I\1V3[CG_8L<=F,] M+8>>=WH.WID!.ERJQY ![R8W>CV\.0;O!-P)AS&)E,IZ?J?9ZIJ&RU)M%$[5 M)9[WV=] V5_*B_5_947\7TXTU4J\L4]AHU4#VG(P^Z?C'50:2G<$387[I?W1 M:!BZ1'K$"_^'$^C,+@ 8=S>^W,6NGMZ%?6J<"^/&(H?^X?$&*4\MW%! G MUMT1;YT=<38++I5[]0>HT]W=?#SZ7O'!-MC>6>^.0&ULS9QO;]NZ%<;?]U-HV9L-N*Q%BA3)HNU%E]L.Q7K;HDEQ M+S8,!O\F0ATID)4F^?:C9#NQ8\D6*5M97S2.0Y_G/"?\63RDG->_WEW-HI^F MG&=%_N8$OHQ/(I.K0F?YQ9N3[^V+%Z__ L"?__CV*?JM4#=7)J^B MT]*(RNCH-JLNH^K21'\4Y8_LIXB^SD1EB_(*@+?-RTZ+Z_LRN[BL(A0CO!JV M^FGY*J6,Q40C0+3D *>$ .X> DNY-M)RG%K]R\4K([GF"!% 5"P!3A((1.R& M*4.53HF4 IHFZ"S+?[RJ_Y-B;B)G+Y\WW[XYN:RJZU>3R>WM[%N7% M!,5Q,EF-/ED.O]L:?YLTHR'G?-+\]&'H/&L;Z,+"R9^_?SI3E^9*@"R?5R)7 MM< \>S5OGOQ4*%$U5=^;5]0YHOX.K(:!^BD $4C@R[NY/GG[(HH6Y2B+F?EF M;%1__?[M8ZL!DFOL?CY4CKMJ^OE@ MZ9Z[=PAS_(379 :GO)A0[W,]UMQ]D!J<^O$S/M2T*"HQ&V%:/,JLI3RKG_CD M'BUEZD [WDP;G>5;]UJJYJXRN3:+=\N-T%&FWYRX1U-MLNF943=E5MV_OU.7 M(K\PG\65F4(;RY@("#26 F#&$6"$I\ JEO"8QHP(/JT>YO34Y.#[V4J^T=@M M<.+AK.H@M#3SXJ94BVN;$ZVOZXL\WJXDHY5F5(N^GCRF%U"3V=&=SHYILE ; M@6?U1;HHGSHIU%XGCY-^[JPT-N9&O;PH?D[<2YT=E-0/0/V@F>N= 2=;OX5W MY2I+4:H])5N.F*C"K3^N*[!1/5L65_WL5$6_7^"B;$[T)"I*;4JWIFPQT#J- M()+G634ST]@H*13$P IMW%(/"2 D54 P@8RQ,N9I[(O5*OB1D6HTHL)&$/U- M_CU:J?LS]5",_CR%6/1CR===$$Q/;0P"Z2'8Z! ]M=$&T-88?WC^<''RT MN+JZR;-%1S&?,FRTZU4TX-1B@+GB@$F2 )9(1:'4')O>!+4J'!FCI6:T*=J? MHO:J[$=IL%<_GCQM>N&TTTH04^T11P-KIZ%UNG8/]$>L;M1G7R^+W'R^N9*F MG$)%J>*& ,@$!Q@*"1@C"BB*.(/NG]))7[J>!C\R6(U1AS NC+@=!!&T%&PV>+AOKW'2.\4?FO!3U#N+9_94L9E,B88H%8H#' MK.;%Q(!A0@&BVIHX0QL1EI-#!:#:Q3T3[ 'XGW>>56?!]S59371=EN@=&9]%!M%&"K]$31*N:M$RD:C. MI#];?/PT/4Q0M2#[=!Z/:)/QK0'F;7,?=Y62C\[[1VTV+>Q/U2 M?BV+GYFS,T608"F5!"BQQE&?2""030"Q1LD84D8L\Z.^76@\+ M>4>Y^M(]O A!6 ?X#X!YM[D!%'<$'AG?W?:VN=TSWA_8KZ6I^T?CHM2GW1_G M\QM3GM<'!>47:UWODU";@Q">6_PT7#N:W,=Z=ZO M\<=Z=??*PX'M;^X-8YHB0F-.+4@QL@!38EVGBC@@QI*4RUA;A?JRW*IP9( ? M[LE9B$9.-:IE^T/;7I?]I YVZX>GMU$O)'>:">*P/>)H\.TTM$[<[H'^F)T6 M/TWY3LZK4JBJQS3:&'^\Z=/(1/]9"?WW,-.F-?F@Z;(9:;1ITFI@?7JT#PCM M@MY?F?(BRR_^61:WU:5[I[\6^?V44()XHA"@U-9W 7(.1,I3(&U"8:Q%FE#I MUP2UZHS3 ZVDHX5VM!3W;8#:*]6W_QGL/ZC]\;4>T/OL-#:@]6F/.W+GL]/< M=N.S>_C@OF=]W1ZG!,7**F!LD@",L%LEU??CIBC6/(VQT88$=CS/V.L_'*9S.2MFFX^6+-"19T?6SXQ?/]:2>5@[MAYH MO&ZL)?V-9JSMYP-/I+X6\TK,_IU=-Y-#0*%82CDP6EF -4= 2'>9(5IC1X9( M8I4&G4=MR(Q\&K70CIQXT(%S:Z'Z=F)#[0!:29"RU!@L(>:R=]^U'GBL3>E: MRW\GNK'>?P/:UU#@OO-.+T&;S>N)#]IC;@*-OK6\GG[;CO+&S_U!>.=BZ#K. MAYFXF"*A$D0%!RQ.$X MQ4 F# %B(:<<"Y9@W9>$C_&CH:<<+A];4@WC8C#0:$*T&UHEH'Q"Z<#MU@4HQ^YAK<_)-L!M MT.JLO]& 95F'F0$KLJ<11UZ,=1C:7H=U#0P^J[H[+T4^S^K; 1>'HU.%(>&Q MUD!080#&/ %2,@*TXH(D,4R)]>R.MD5&.J6ZBQZ%ET?JWD=4VP7JB]PPVT'4 M>3D..9GJM#3D6&H[Z-AG4IVV6@ZDNL>&0O@AFZT^<<0-ERF4!AB*4H 1)$#P MF 9$VMC'$,F/&^0?PP^#G2UGOQ,'=!;/4Q%H#4MH,!**T%&QFA M;1O;Z+2,&;BO5^\5?BG/B]M\*KD6UN#Z0_36]4Z0&, X@P RA1U5)D:\]V>P M.C1&WM%K]HZ+,JJE [?SUNKCN9<7YGK81EXOP^&[>-N6AF_AK<5\GOV[;5.= MFWH I!:/H7( #//>8&0-H5>614]QC M-9=?/F6Y@5.K$H2) Q5)"@%FE %F+0?4R)B;1 E%PCZ>AAV$:=/*^?H>Z'74%[&P^_BK89&WX=W8CZ/%?2-F.=U]+6P8?#$DT19RIV M2UH .3, 7^@%CN,GX0+-%1 ML$3/CR7RP1(-QO*;N(.QA]O7ZR>R19_R?GMB_\!4$L#!!0 ( &B C%@S_RUZ#0< PU 4 M =7!H+3(P,C0P-#$Q7W!R92YX;6S5FVU3XS@2Q]_/I\CEWIZ().N1&MCB MV)DKZM@=:H:MW;HW*3VT$MKH_DOE^^)F?]P_.;-V[\1\ML_/Y[/ M?JS"U0;*9G9:@VL@SJ[S9CUKUC#[M:I_SS^[V47AFE35&T*.NVZGU?:VSE?K M9L8I%_MF^[/UH=+&4!DYD=%;(I24Q.)7DK2-X),5*L5_K [!VV@YET0&ZHG( M,D8N\8=!&UL N/]QU!\^KX)I.]?\YKMDW6[2_R+X9:0\1QDG&#FYV<7[\9C:[DZ.N M"O@(:=;^_>7CV1>35]LUN*)9YV4X"-5FT9Y?G%;( XZTZ]G<;N%HOLLWVP+V MQ]8UI*,Y]B6M1ZE@G;F_W_5;?+6ZK6&'J'2S/,<#]]U;(W]Y!'#30!GA;E)[ M T45'C4J6DFK+ST+YZ'HCBXCY,ONJB=^U]0N-,OD(XA (TG*9XB=,L0RH0F/ M*;->,V.%>3SA=L0[''+G@1V$@U7U>8$71D_PK/W2RI%U4CPQ=R?+R\:]O^4N ML>U24L48BXY0HP,1DEMB#%,D:AVM#1*4%(.&_=#:XU$_=.=)'695':'&-6-O MSM7AD6N?TGK?8K%U-5Z(A'5>Q'WO5%>;,7S55",H=^<6'.Y\AK-.4-<0S^^\ M\LW)=3-K<"6%KN48'K^ .J_BNS+^B$OMDDH=C6N71P:"B!"!. !*!*.@F<"; M0\,HKG]DMA<#?/H,O%S+5X;A7=GDS>U'6.6M$F7SL]O ,L3(>< =+Q."X:A- M(D9()%HYGME,6D_U(!:>L]H+A6RZ* Q6),HP+I(*M6$N8IBD$K$J9298L$FD$<#XTT'TXD1,G9/Q=)X$-N_S M GZ^VGBHE]QG&:5"D9!EA@@'G%C#'C,R0X/4:HSEXAOF>W&A MIL[%&-I. I*3&-$%N_L_F+$!6[+ M9T%A MOQ,H7JCGE)#H N8/]45=?<[+ ,O$96:9CT0QAVFVB888:?"#R\@PW0;JQP@T MGK?>KXY%OQ,ZAD@[)40NJEWCBO_DVRZA A&U9$H3J@$W11V >)<4D%H5[V3&MQ=?LTLU<9Q$JA J#T7Q$5EB=*,@M4F M888]K#S_P%H_ "9!Q*U MI+;-$/8\X8H8[ M&Q%"(K_2,X+)-"YB&?)K_" &GC7;#X0)5RV'B_G*-'RJBCSD35ZN?L( I\Y= ML6RW)\ZT)I):C'Z#XAC5@"(B*>89C3:+PRJ53VWVXV#"Q-1464TP9BF+;E'3RQH3QR3T@4N$FYZ@V#XMNU^4$RX M4CF2K-."XVRWNX+ZX5QX! :&!Y(%D7"U$X&8E"BFS)1CMBRU4'9,1)Z,H!\H M$ZY:CBKQ:V\H$*YP4[QEW%_F38&9LM9,LH29LI:<".H#\4%Z$FW0*3"+F@Q; M0?YHL1\.$ZY5#I+PE=U_6;OV-<9/MQM?%4N?0 K%#.' 6P5D1BQ7CB1)/<04 M=?39(-\_,M?/\1.N1[Y\LAXYBUX0Y+%1%AH'HD1N&B) MR").A+&8L5%N_(=6^[TY->&JXV I)U%M?+>!>H4H_ZNNKILU;FY;5]XN#3#, MBBDCJGW\)E2,Q&H1V]=^J!!>0;1R$!%_8KP?&).O-PX7=AI\W.!:5^[R5O^[ MEP27@%.G-$G">60X!R>(-2@.-2E2:KRU88R'%4\M]R-CPH7(422=!!:GJ%?M MBC.,?&_^#;=+Y9F)&C-G8!K7/8Q^49& .R(S/!I0GMIA[XL_:[8?$!,N3PX7 M\Y5I.,$T*+:IT/O"K992,A%48"3(]B7R3$;BH_,D81@DG*5&1#Z(@D?F^GE_ MPC7)EXLWFM??+IZ(=XX'CM_.7[S7U!+ 0(4 Q0 ( &B C%CI MB<\[NAD ,.W > " 0 !E>&AI8FET,3 Q+6EC861M M:6YI'-D4$L! A0#% @ :(",6+NK"&N2"@ F5L !0 ( ! M 3, '5P:"TR,#(T,#0Q,5]L86(N>&UL4$L! A0#% @ :(",6#/_+7H- M!P ##4 !0 ( !Q3T '5P:"TR,#(T,#0Q,5]P&UL 64$L%!@ % 4 3 $ 1% $! end XML 17 uph-20240411_htm.xml IDEA: XBRL DOCUMENT 0001770141 2024-04-11 2024-04-11 0001770141 false 8-K 2024-04-11 UpHealth, Inc. DE 001-38924 83-3838045 14000 S. Military Trail Suite 203 Delray Beach FL 33484 888 424-3646 false false false false Common Stock, par value $0.0001 per share UPH(1) NYSE true false